Riccardo Raneri – Pagina 124

Febbraio 26, 2015 Riccardo Raneri

Use of non-steroidal anti-inflammatory drugs and risk of chronic kidney disease in people with Type 2 diabetes mellitus, a nationwide longitudinal cohort study

Diabetic Medicine. 2015;32(3):382-90 http://onlinelibrary.wiley.com/doi/10.1111/dme.12610/abstract;jsessionid=43AAD1346FE8EC1C1404E41FA936F933.f03t03

Leggi

Febbraio 24, 2015 Riccardo Raneri

Treating obesity seriously: when recommendations for lifestyle change confront biological adaptations

Christopher N Ochnere, Adam G Tsai, Robert F Kushner et al. Lancet Diabetes &Endocrinology. Published Online February 2015 http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00009-1/abstract

Leggi

Febbraio 24, 2015 Riccardo Raneri

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Erik S. Stroes , Paul D. Thompson, Alberto Corsini et al. European Heart Journal. Published online February 18, 2015 http://eurheartj.oxfordjournals.org/content/early/2015/02/18/eurheartj.ehv043.abstract?papetoc

Leggi

Febbraio 26, 2015 Riccardo Raneri

Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy

Am J Nephrol. 2015;40:572-81 http://www.karger.com/Article/Abstract/371497

Leggi

Febbraio 19, 2015 Riccardo Raneri

Associations Between Ozone and Preterm Birth in Women Who Develop Gestational Diabetes

Am. J. Epidemiol. Vol 181 (4): 280-287. February 2015 http://aje.oxfordjournals.org/content/181/4/280.abstract?etoc

Leggi

Febbraio 25, 2015 Riccardo Raneri

Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?

Diabetes Care. 205;38(3):373-5 http://care.diabetesjournals.org/content/38/3/373?etoc

Leggi

Febbraio 10, 2015 Riccardo Raneri

Treating Hypertension in Patients With Diabetes. When to Start and How Low to Go?

Bryan Williams JAMA. 2015;313(6):573-4 http://jama.jamanetwork.com/article.aspx?articleid=2108870

Leggi

Febbraio 19, 2015 Riccardo Raneri

Fetal programming via maternal diabetes: the controversy continues

Diabetic Medicine. Vol 32 (3) : 291–294, March 2015 http://onlinelibrary.wiley.com/doi/10.1111/dme.12675/abstract

Leggi

Febbraio 26, 2015 Riccardo Raneri

Racial-Ethnic Disparities in Management and Outcomes Among Children With Type 1 Diabetes

Pediatrics. Published online February 2015 http://pediatrics.aappublications.org/content/early/2015/02/10/peds.2014-1774.abstract

Leggi

Febbraio 25, 2015 Riccardo Raneri

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin

Diabetes Care. 2015;38(3):376-83 http://care.diabetesjournals.org/content/38/3/376?etoc

Leggi